Found 5 matching trials
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
PHASE1Background:
Immunotherapy drugs help the body to fight cancer. Scientists ...
Location
National Institutes of Health Clinical Center
Safety and Tolerability Trial (MVA-BN-Brachyury/FPV-Brachyury)
PHASE1An open-label Phase 1 trial to evaluate the safety and tolerability of MVA-...
Location
Genitourinary Malignancies Branch National Cancer Institute
BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)
PHASE1Background:
Breast cancer is the second most common cause of United States...
Location
National Institutes of Health Clinical Center
BN Brachyury and Radiation in Chordoma
PHASE2The goal of this study is to determine if the combination of BN-Brachyury p...
Location
Mayo Clinic, Arizona
N-803 Alone or in Combination With BN-Brachyury Vaccine or Bintrafusp Alfa (M7824) for Participants With Castration Resistant Prostate Cancer
PHASE2Background:
Prostate cancer does not trigger a strong immune response in t...
Location
National Institutes of Health Clinical Center